Now showing items 1-1 of 1
miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancer
(Journal article / Tidsskriftartikkel / PublishedVersion; Peer reviewed, 2019)
One of the hallmarks of cancer is sustained angiogenesis. Favorable results have been reported in some breast cancer (BC) patients receiving antiangiogenic therapy with bevacizumab (Bev) in combination with chemotherapy, ...